Modulating the Gut–Muscle Axis: Increasing SCFA-Producing Gut Microbiota Commensals and Decreasing Endotoxin Production to Mitigate Cancer Cachexia
Cancer cachexia is a multi-organ and multifactorial syndrome characterized by muscle wasting (with or without adipose tissue loss) and systemic inflammation in patients with advanced malignancies. Gut microbiota dysbiosis, particularly the depletion of short-chain fatty acid (SCFA)-producing bacteri...
Saved in:
Main Authors: | Sagnik Roy, Amir Hossein Alizadeh Bahmani, Mark Davids, Hilde Herrema, Max Nieuwdorp |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/13/6/1356 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut Microbiota in Primary Sarcopenia: Mechanisms and Potential Therapeutic Targets
by: Leshan Chen, et al.
Published: (2025-05-01) -
Exploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis
by: Chuanjian Yuan, et al.
Published: (2025-07-01) -
Gypenosides Alleviate Hyperglycemia by Regulating Gut Microbiota Metabolites and Intestinal Permeability
by: Rong Wang, et al.
Published: (2025-07-01) -
Possibilities of using branched-chain amino acids for the treatment and prevention of sarcopenia in elderly and old patients (literature review)
by: D. P. Kurmayev, et al.
Published: (2023-07-01) -
Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation
by: Xiaoran Wang, et al.
Published: (2025-06-01)